Heart Archives - Page 5 of 6

New Pharma Invention Index Picks AstraZeneca as Top Company

Artificial Intelligence, Business, Cancer, Cardiovascular (CV) Death, Chronic Kidney Disease, Coronary Heart Diseases, Heart Attacks, Idiopathic Pulmonary Fibrosis, Invention, Machine Learning, Oncology, Product Pipelines, Strokes, Type 2 Diabetes

AstraZeneca topped the first annual Pharmaceutical Invention Index, released by IDEA Pharma.

November 5, 2019/by BioSpace

Pfizer raises 2019 forecast, Q3 profit tops estimates

Blockbusters, Breast Cancer, Business, Cancer, Forecasts, Generics, Heart, Investors, Profitability, Quarterly results, Rheumatoid Arthritis, Sales, Shares, Spin-offs, Wall Street Analysts, Wall Street Estimates

Pfizer Inc. reported a higher-than-expected third-quarter 2019 profit on increased sales of the cancer drug Ibrance and a strong launch of the new heart medicine Vyndaqel.

October 29, 2019/by Reuters Health

Bristol-Myers Squibb-Pfizer Alliance and Fitbit Collaborate to Address Gaps in Atrial Fibrillation Detection

Alliances, Atrial Fibrillation, Business, Fitbit, Heart Rhythm, Stroke, Wearables

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of atrial fibrillation (AFib) with the aim of improving earlier detection in individuals at increased risk of stroke.

October 17, 2019/by Business Wire

FDA approves Clinuvel’s rare genetic disorder drug

Approvals, Erythropoietic Protoporphyria (EPP), FDA, FDA/Regulatory, Genetic Mutations, Implants, Shares

The U.S. Food and Drug Administration approved Clinuvel Pharmaceuticals Ltd.’s treatment for a rare inherited disorder that causes skin damage from exposure to light, sending the Australian drugmaker’s shares to a record high.

October 8, 2019/by Reuters Health

Few supplements have proven heart benefits

Analysis, Cardiovascular Disease, Chronic Diseases, Dietary Guidelines, Heart Problems, Minerals, Normal Blood Pressure, Nutritional supplements, Research, Stroke, Vitamins

Few nutritional supplements can protect people from developing or dying from cardiovascular disease, and some may actually be harmful, a research review suggests.

July 9, 2019/by Reuters Health

Without heart disease, daily aspirin may be too risky

Aspirin, Brain Bleeding, Heart Attacks, Heart Diseases, R&D, Research, Strokes

For people without heart disease, taking a daily aspirin to prevent heart attacks and strokes may increase the risk of severe brain bleeding to the point where it outweighs any potential benefit, a research review suggests.

May 13, 2019/by Reuters Health

Alphabet’s GV leads funding in gene editing company Verve Therapeutics

Biotech, Business, Company Launches, Gene Editing, Heart Diseases, Human Genome, Venture Capital, Venture Investmets

Alphabet’s venture capital arm GV led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.

May 7, 2019/by Reuters Health

Apple Watch detects irregular heartbeat in U.S. study

Apple Watch, Atrial Fibrillation, Consumer Technology, Consumers, Devices, Heart Rhythm, R&D, Researchers, Wearables, Wearables

The Apple Watch was able to detect irregular heart pulse rates that could signal the need for further monitoring for a serious heart rhythm problem, according to data from a large study funded by Apple Inc.

March 16, 2019/by Reuters Health

Abbott Offers a New Option for Physicians Treating Patients with Atrial Fibrillation

3D Mapping, Approvals, Atrial Fibrillation, Cardiac, Catheters, FDA, FDA/Regulatory, Health Technology, Heart, Heart tissue, Patients, Physicians

Abbott announced U.S. Food and Drug Administration approval of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, a new ablation catheter designed to help physicians accurately and effectively treat atrial fibrillation (AFib).

January 21, 2019/by PR Newswire

FDA Approves World’s First Device for Treatment of Premature Babies and Newborns with an Opening in Their Hearts

Approvals, Babies, FDA, FDA/Regulatory, Heart, Medical Devices, Newborns

Abbott announced the U.S. Food and Drug Administration approved the Amplatzer Piccolo Occluder, the world’s first medical device that can be implanted in the tiniest babies using a minimally invasive procedure to treat patent ductus arteriosus (PDA).

January 14, 2019/by PR Newswire